These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9099837)

  • 21. Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene.
    Mottes M; Sangalli A; Valli M; Gomez Lira M; Tenni R; Buttitta P; Pignatti PF; Cetta G
    Hum Genet; 1992 Jul; 89(5):480-4. PubMed ID: 1634225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderately severe osteogenesis imperfecta associated with substitutions of serine for glycine in the alpha 1(I) chain of type I collagen.
    Marini JC; Lewis MB; Chen K
    Am J Med Genet; 1993 Jan; 45(2):241-5. PubMed ID: 8456809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation producing alternative splicing of exon 26 in the COL1A2 gene causes type IV osteogenesis imperfecta with intrafamilial clinical variability.
    Zolezzi F; Valli M; Clementi M; Mammi I; Cetta G; Pignatti PF; Mottes M
    Am J Med Genet; 1997 Aug; 71(3):366-70. PubMed ID: 9268111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV.
    Lund AM; Nicholls AC; Schwartz M; Skovby F
    Acta Paediatr; 1997 Jul; 86(7):711-8. PubMed ID: 9240878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mild variant of osteogenesis imperfecta type I caused by a Gly1088Glu mutation in COL1A1.
    Xia XY; Li WW; Li N; Wu QY; Cui YX; Li XJ
    Mol Med Rep; 2014 Jun; 9(6):2187-90. PubMed ID: 24682174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta.
    Nicholls AC; Oliver J; McCarron S; Winter GB; Pope FM
    Hum Mutat; 1996; 7(3):219-27. PubMed ID: 8829655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycine to tryptophan substitution in type I collagen in a patient with OI type III: a unique collagen mutation.
    Nuytinck L; Tükel T; Kayserili H; Apak MY; De Paepe A
    J Med Genet; 2000 May; 37(5):371-5. PubMed ID: 10807697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two novel distinct COL1A2 mutations highlight the complexity of genotype-phenotype correlations in osteogenesis imperfecta and related connective tissue disorders.
    Reuter MS; Schwabe GC; Ehlers C; Marschall C; Reis A; Thiel C; Graul-Neumann L
    Eur J Med Genet; 2013 Dec; 56(12):669-73. PubMed ID: 24140640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta.
    Thompson EM; Young ID; Hall CM; Pembrey ME
    J Med Genet; 1987 Jul; 24(7):390-405. PubMed ID: 3612715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteogenesis imperfecta with ectopic mineralizations in dentin and cementum and a COL1A2 mutation.
    Kantaputra PN; Sirirungruangsarn Y; Intachai W; Ngamphiw C; Tongsima S; Dejkhamron P
    J Hum Genet; 2018 Jul; 63(7):811-820. PubMed ID: 29636545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteine in the triple helical domain of the pro alpha 2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta.
    Cohn DH; Byers PH
    Hum Genet; 1991 Jun; 87(2):167-72. PubMed ID: 2066103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
    Ward LM; Lalic L; Roughley PJ; Glorieux FH
    Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent mutations in the COL1A2 gene in patients with osteogenesis imperfecta.
    Trummer T; Brenner R; Just W; Vogel W; Kennerknecht I
    Clin Genet; 2001 May; 59(5):338-43. PubMed ID: 11359465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
    Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
    Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta.
    Becker J; Semler O; Gilissen C; Li Y; Bolz HJ; Giunta C; Bergmann C; Rohrbach M; Koerber F; Zimmermann K; de Vries P; Wirth B; Schoenau E; Wollnik B; Veltman JA; Hoischen A; Netzer C
    Am J Hum Genet; 2011 Mar; 88(3):362-71. PubMed ID: 21353196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitutions in the alpha 2-chain of type I collagen.
    Rose NJ; Mackay K; De Paepe A; Steinmann B; Punnett HH; Dalgleish R
    Hum Genet; 1994 Nov; 94(5):497-503. PubMed ID: 7959683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation.
    Forlino A; D'amato E; Valli M; Camera G; Hopkins E; Marini JC; Cetta G; Coviello DA
    Biochem Mol Med; 1997 Oct; 62(1):26-35. PubMed ID: 9367795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confirmation of the pathogenicity of a mutation p.G337C in the COL1A2 gene associated with osteogenesis imperfecta.
    Jia M; Shi R; Zhao X; Fu Z; Bai Z; Sun T; Zhao X; Wang W; Xu C; Yan F
    Medicine (Baltimore); 2017 Sep; 96(39):e7783. PubMed ID: 28953610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.